Search hospitals > California > Lancaster
Om Research LLC
Claim this profileLancaster, California 93534
Global Leader in Ulcerative Colitis
Global Leader in Ulcer
Conducts research for Inflammatory Bowel Disease
Conducts research for Crohn's Disease
Conducts research for Fatty Liver Disease
68 reported clinical trials
4 medical researchers
Summary
Om Research LLC is a medical facility located in Lancaster, California. This center is recognized for care of Ulcerative Colitis, Ulcer, Inflammatory Bowel Disease, Crohn's Disease, Fatty Liver Disease and other specialties. Om Research LLC is involved with conducting 68 clinical trials across 61 conditions. There are 4 research doctors associated with this hospital, such as Jatinder Pruthi, Karen Simon, Neera Grover, and Jatinder Jatinder.Top PIs
Jatinder PruthiOM Research2 years of reported clinical research
Studies Ulcerative Colitis
Studies Ulcer
12 reported clinical trials
11 drugs studied
Karen SimonOm Research, LLC2 years of reported clinical research
Studies Crohn's Disease
Studies Colorectal Cancer
6 reported clinical trials
5 drugs studied
Neera GroverOm Research LLC2 years of reported clinical research
Studies Celiac Disease
1 reported clinical trial
1 drug studied
Jatinder JatinderOm Research LLC2 years of reported clinical research
Studies Ulcerative Colitis
Studies Inflammatory Bowel Disease
1 reported clinical trial
2 drugs studied
Clinical Trials running at Om Research LLC
Ulcerative Colitis
Ulcer
Inflammatory Bowel Disease
Crohn's Disease
Eosinophilic Esophagitis
Cholangitis
Coronavirus
Esophagitis
Primary Biliary Cirrhosis
Liver Cirrhosis
Ozanimod
for Ulcerative Colitis
The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice.
Recruiting4 awards Phase 4
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
SHR0302
for Ulcerative Colitis
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Om Research LLC?
Om Research LLC is a medical facility located in Lancaster, California. This center is recognized for care of Ulcerative Colitis, Ulcer, Inflammatory Bowel Disease, Crohn's Disease, Fatty Liver Disease and other specialties. Om Research LLC is involved with conducting 68 clinical trials across 61 conditions. There are 4 research doctors associated with this hospital, such as Jatinder Pruthi, Karen Simon, Neera Grover, and Jatinder Jatinder.